BACKGROUND: Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening complication of diabetes mellitus, responsible for up to 40 % of diabetes-related morbidity and mortality. Despite its use in severe cases of pediatric DKA, bicarbonate therapy remains controversial due to potential associations with adverse outcomes such as cerebral edema.
OBJECTIVES: Prior studies evaluating bicarbonate therapy in pediatric DKA have been limited by confounding variables, small sample sizes, and short follow-up periods. This study aims to evaluate the association between bicarbonate therapy and adverse outcomes using a large clinical dataset, extended follow-up, and propensity score (PS) matching to control for baseline differences.
METHODS: We conducted a retrospective cohort study using TriNetX, a global research network of deidentified electronic health records. Pediatric DKA patients (<12 years) were stratified by bicarbonate therapy status and matched using PS to reduce confounders. Risk analysis was conducted to assess clinical outcomes.
RESULTS: After PS matching, each cohort included 211 patients. No significant difference in cerebral edema was observed between groups (RD = 0.002; 95 % CI: -0.039 to 0.044; p = 0.911). However, bicarbonate use was associated with higher risks of coma (RD = 0.047; p = 0.001), pulmonary edema (RD = 0.048; p = 0.001), and acute respiratory failure (RD = 0.071; p = 0.008).
CONCLUSION: Although bicarbonate therapy was not linked to increased cerebral edema, it was associated with significant respiratory and neurologic complications. These findings suggest that clinicians should use bicarbonate cautiously and that current treatment guidelines may warrant reevaluation.
| Discipline Area | Score |
|---|---|
| Pediatric Emergency Medicine |  |
| Emergency Medicine | |
| Endocrine | |
This retrospective observational study asks whether bicarbonate is beneficial for pediatric patients with diabetic ketoacidosis (DKA)? Groups (+/- bicarbonate) were matched by propensity scoring. The rarity of DKA makes an RCT difficult to conduct. Bicarbonate increases the risk for pulmonary edema, coma, and respiratory failure by 5%, 5%, and 7%, respectively. No statistically significant differences in potassium abnormalities or mortality were found. The limitations include lack of randomization and that only one outcome (mortality) was necessarily important to patients. Whether coma was reversible was not mentioned nor was length of hospital stay or things patients would be interested in (for example, final neurological and functional status).
A good reminder on use of bicarbonate. I have yet to use it, even in severe DKA. I practice PEM.
